Medicines for All

We make high-quality medicines accessible to patients and healthcare professionals where and when they are needed most. Through development, manufacturing, and international marketing, we bring proven and innovative treatments to high-growth markets.

Our portfolio has grown through strategic in-licensing and acquisitions, positioning us for continued expansion. Trusted by partners worldwide, we deliver effective therapies and provide contract manufacturing and out-licensing through our world-class facilities and manufacturing network.

  • 0

    Product Marketing Authorisations

  • 0

    Countries (commercial)

Treatments for Patients in Selected Markets

Acino is a Swiss pharmaceutical company with a strong presence in the Middle East, Türkiye and North Africa, French- and English-speaking Africa, Ukraine and Eurasian countries, as well as Latin America.

Our broad product portfolio includes:

  • Prescription (Rx) medicines
  • Over-the-counter (OTC) products
  • A wide wide range of food supplements.

We provide originator brands, which are protected by patents or data exclusivities, and branded generics, which are equivalent substitutes to their originator products.

Please note: Product availability and marketing authorisations vary by country. For more information, visit your local Acino website or contact us directly.

 

Therapeutic Areas

Our global portfolio spans a wide range of therapeutic areas, with a particular focus on Cardiovascular & Metabolism, Gastroenterology, Infectious diseases, Neurosciences, and Pain & Rheumatology.

 

  • Aesthetics

  • Allergology

  • Cardiovascular & Metabolism

  • Cold & Cough

  • Dermatology

  • Gastroenterology

  • Iron deficiencies

  • Infectious diseases

  • Men’s Health

  • Neurosciences

  • Oncology

  • Pain & Rheumatology

  • Vitamins/Supplements

  • Women’s Health

Latest News